Amedisys Inc (AMED)
NASDAQ:AMED
Holding AMED?
Track your performance easily

Amedisys (AMED) Stock Forecast & Price Target

447 Followers
See the Price Targets and Ratings of:

AMED Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Amedisys
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AMED Stock 12 Month Forecast

There Are No Analyst Ratings for AMED In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

AMED Financial Forecast

AMED Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

AMED Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen
$101
Hold
5.88%
Upside
Assigned
07/29/24
Amedisys: Hold Rating Affirmed Amidst Modest EBITDA Adjustments and Acquisition Offer
Deutsche Bank
$101
Hold
5.88%
Upside
Downgraded
07/26/24
Amedisys downgraded to Hold from Buy at Deutsche BankAmedisys downgraded to Hold from Buy at Deutsche Bank
Truist Financial
Hold
Assigned
07/25/24
Truist Financial Gives a Hold Rating to Amedisys (AMED)
Jefferies
$101
Hold
5.88%
Upside
Reiterated
07/25/24
William Blair
Hold
Downgraded
07/01/24
Amedisys downgraded to Market Perform from Outperform at William BlairAmedisys downgraded to Market Perform from Outperform at William Blair
Cantor Fitzgerald
$101
Hold
5.88%
Upside
Reiterated
04/24/24
Analysts Offer Insights on Healthcare Companies: Amedisys (NASDAQ: AMED) and Gilead Sciences (NASDAQ: GILD)
RBC Capital
$100
Buy
4.83%
Upside
Reiterated
03/25/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amedisys (NASDAQ: AMED) and Masimo (NASDAQ: MASI)
Leerink Partners
$101
Hold
5.88%
Upside
Reiterated
03/04/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: PepGen Inc. (NASDAQ: PEPG), BridgeBio Pharma (NASDAQ: BBIO) and Amedisys (NASDAQ: AMED)

Best Analysts Covering Amedisys

Which Analyst Should I Follow If I Want to Buy AMED and Sell After:
1 Month
xxx
Success Rate
3/8 ratings generated profit
38%
Average Return
-4.69%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 37.50% of your transactions generating a profit, with an average return of -4.69% per trade.
3 Months
xxx
Success Rate
1/8 ratings generated profit
13%
Average Return
-9.10%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 12.50% of your transactions generating a profit, with an average return of -9.10% per trade.
1 Year
Ben HendrixRBC Capital
Success Rate
3/8 ratings generated profit
38%
Average Return
-11.55%
reiterated a buy rating 8 months ago
Copying Ben Hendrix's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -11.55% per trade.
2 Years
xxx
Success Rate
3/8 ratings generated profit
38%
Average Return
-8.20%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 37.50% of your transactions generating a profit, with an average return of -8.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AMED Analyst Recommendation Trends

Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
0
0
0
0
0
Buy
1
1
1
0
0
Hold
4
5
5
4
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
6
6
4
8
In the current month, AMED has received 0 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. AMED average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AMED Stock Forecast FAQ

What is AMED’s average 12-month price target, according to analysts?
Currently, no data Available
What is AMED’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AMED, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is AMED a Buy, Sell or Hold?
      Currently, no data Available
      What is Amedisys Inc’s price target?
      Currently, no data Available
      What do analysts say about Amedisys Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of AMED?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis